Global Molecular Diagnosis of Rectal Cancer Market Size, Status and Forecast 2021-2027

Global Molecular Diagnosis of Rectal Cancer Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Molecular Diagnosis of Rectal Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnosis of Rectal Cancer Market Perspective (2016-2027)
2.2 Molecular Diagnosis of Rectal Cancer Growth Trends by Regions
2.2.1 Molecular Diagnosis of Rectal Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Molecular Diagnosis of Rectal Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Molecular Diagnosis of Rectal Cancer Industry Dynamic
2.3.1 Molecular Diagnosis of Rectal Cancer Market Trends
2.3.2 Molecular Diagnosis of Rectal Cancer Market Drivers
2.3.3 Molecular Diagnosis of Rectal Cancer Market Challenges
2.3.4 Molecular Diagnosis of Rectal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnosis of Rectal Cancer Players by Revenue
3.1.1 Global Top Molecular Diagnosis of Rectal Cancer Players by Revenue (2016-2021)
3.1.2 Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Molecular Diagnosis of Rectal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnosis of Rectal Cancer Revenue
3.4 Global Molecular Diagnosis of Rectal Cancer Market Concentration Ratio
3.4.1 Global Molecular Diagnosis of Rectal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis of Rectal Cancer Revenue in 2020
3.5 Molecular Diagnosis of Rectal Cancer Key Players Head office and Area Served
3.6 Key Players Molecular Diagnosis of Rectal Cancer Product Solution and Service
3.7 Date of Enter into Molecular Diagnosis of Rectal Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnosis of Rectal Cancer Breakdown Data by Type
4.1 Global Molecular Diagnosis of Rectal Cancer Historic Market Size by Type (2016-2021)
4.2 Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Type (2022-2027)
5 Molecular Diagnosis of Rectal Cancer Breakdown Data by Application
5.1 Global Molecular Diagnosis of Rectal Cancer Historic Market Size by Application (2016-2021)
5.2 Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Molecular Diagnosis of Rectal Cancer Market Size (2016-2027)
6.2 North America Molecular Diagnosis of Rectal Cancer Market Size by Type
6.2.1 North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2021)
6.2.2 North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2022-2027)
6.2.3 North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2027)
6.3 North America Molecular Diagnosis of Rectal Cancer Market Size by Application
6.3.1 North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2021)
6.3.2 North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2022-2027)
6.3.3 North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2027)
6.4 North America Molecular Diagnosis of Rectal Cancer Market Size by Country
6.4.1 North America Molecular Diagnosis of Rectal Cancer Market Size by Country (2016-2021)
6.4.2 North America Molecular Diagnosis of Rectal Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Molecular Diagnosis of Rectal Cancer Market Size (2016-2027)
7.2 Europe Molecular Diagnosis of Rectal Cancer Market Size by Type
7.2.1 Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2021)
7.2.2 Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2022-2027)
7.2.3 Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2027)
7.3 Europe Molecular Diagnosis of Rectal Cancer Market Size by Application
7.3.1 Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2021)
7.3.2 Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2022-2027)
7.3.3 Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2027)
7.4 Europe Molecular Diagnosis of Rectal Cancer Market Size by Country
7.4.1 Europe Molecular Diagnosis of Rectal Cancer Market Size by Country (2016-2021)
7.4.2 Europe Molecular Diagnosis of Rectal Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size (2016-2027)
8.2 Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Diagnosis of Rectal Cancer Market Size (2016-2027)
9.2 Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type
9.2.1 Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2027)
9.3 Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application
9.3.1 Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2027)
9.4 Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country
9.4.1 Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size (2016-2027)
10.2 Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Kingmed
11.1.1 Kingmed Company Details
11.1.2 Kingmed Business Overview
11.1.3 Kingmed Molecular Diagnosis of Rectal Cancer Introduction
11.1.4 Kingmed Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
11.1.5 Kingmed Recent Development
11.2 Geneis
11.2.1 Geneis Company Details
11.2.2 Geneis Business Overview
11.2.3 Geneis Molecular Diagnosis of Rectal Cancer Introduction
11.2.4 Geneis Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
11.2.5 Geneis Recent Development
11.3 Unitedgene
11.3.1 Unitedgene Company Details
11.3.2 Unitedgene Business Overview
11.3.3 Unitedgene Molecular Diagnosis of Rectal Cancer Introduction
11.3.4 Unitedgene Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
11.3.5 Unitedgene Recent Development
11.4 Yin Feng Gene
11.4.1 Yin Feng Gene Company Details
11.4.2 Yin Feng Gene Business Overview
11.4.3 Yin Feng Gene Molecular Diagnosis of Rectal Cancer Introduction
11.4.4 Yin Feng Gene Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
11.4.5 Yin Feng Gene Recent Development
11.5 Inmedi
11.5.1 Inmedi Company Details
11.5.2 Inmedi Business Overview
11.5.3 Inmedi Molecular Diagnosis of Rectal Cancer Introduction
11.5.4 Inmedi Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
11.5.5 Inmedi Recent Development
11.6 Amoydx
11.6.1 Amoydx Company Details
11.6.2 Amoydx Business Overview
11.6.3 Amoydx Molecular Diagnosis of Rectal Cancer Introduction
11.6.4 Amoydx Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
11.6.5 Amoydx Recent Development
11.7 Genetronhealth
11.7.1 Genetronhealth Company Details
11.7.2 Genetronhealth Business Overview
11.7.3 Genetronhealth Molecular Diagnosis of Rectal Cancer Introduction
11.7.4 Genetronhealth Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
11.7.5 Genetronhealth Recent Development
11.8 Berryoncology
11.8.1 Berryoncology Company Details
11.8.2 Berryoncology Business Overview
11.8.3 Berryoncology Molecular Diagnosis of Rectal Cancer Introduction
11.8.4 Berryoncology Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
11.8.5 Berryoncology Recent Development
11.9 Topgen
11.9.1 Topgen Company Details
11.9.2 Topgen Business Overview
11.9.3 Topgen Molecular Diagnosis of Rectal Cancer Introduction
11.9.4 Topgen Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
11.9.5 Topgen Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Molecular Diagnosis of Rectal Cancer Introduction
11.10.4 Roche Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Molecular Diagnosis of Rectal Cancer Introduction
11.11.4 Qiagen Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
11.11.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Molecular Diagnosis of Rectal Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Molecular Diagnosis of Rectal Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Molecular Diagnosis of Rectal Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Molecular Diagnosis of Rectal Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Molecular Diagnosis of Rectal Cancer Market Share by Regions (2016-2021)
Table 10. Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Molecular Diagnosis of Rectal Cancer Market Share by Regions (2022-2027)
Table 12. Molecular Diagnosis of Rectal Cancer Market Trends
Table 13. Molecular Diagnosis of Rectal Cancer Market Drivers
Table 14. Molecular Diagnosis of Rectal Cancer Market Challenges
Table 15. Molecular Diagnosis of Rectal Cancer Market Restraints
Table 16. Global Molecular Diagnosis of Rectal Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Molecular Diagnosis of Rectal Cancer Market Share by Players (2016-2021)
Table 18. Global Top Molecular Diagnosis of Rectal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis of Rectal Cancer as of 2020)
Table 19. Ranking of Global Top Molecular Diagnosis of Rectal Cancer Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Molecular Diagnosis of Rectal Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Molecular Diagnosis of Rectal Cancer Product Solution and Service
Table 23. Date of Enter into Molecular Diagnosis of Rectal Cancer Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Type (2016-2021)
Table 27. Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Molecular Diagnosis of Rectal Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Application (2016-2021)
Table 31. Global Molecular Diagnosis of Rectal Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Molecular Diagnosis of Rectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Molecular Diagnosis of Rectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Molecular Diagnosis of Rectal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Molecular Diagnosis of Rectal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Molecular Diagnosis of Rectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Molecular Diagnosis of Rectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Molecular Diagnosis of Rectal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Molecular Diagnosis of Rectal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Molecular Diagnosis of Rectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Molecular Diagnosis of Rectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Molecular Diagnosis of Rectal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 63. Kingmed Company Details
Table 64. Kingmed Business Overview
Table 65. Kingmed Molecular Diagnosis of Rectal Cancer Product
Table 66. Kingmed Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021) & (US$ Million)
Table 67. Kingmed Recent Development
Table 68. Geneis Company Details
Table 69. Geneis Business Overview
Table 70. Geneis Molecular Diagnosis of Rectal Cancer Product
Table 71. Geneis Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021) & (US$ Million)
Table 72. Geneis Recent Development
Table 73. Unitedgene Company Details
Table 74. Unitedgene Business Overview
Table 75. Unitedgene Molecular Diagnosis of Rectal Cancer Product
Table 76. Unitedgene Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021) & (US$ Million)
Table 77. Unitedgene Recent Development
Table 78. Yin Feng Gene Company Details
Table 79. Yin Feng Gene Business Overview
Table 80. Yin Feng Gene Molecular Diagnosis of Rectal Cancer Product
Table 81. Yin Feng Gene Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021) & (US$ Million)
Table 82. Yin Feng Gene Recent Development
Table 83. Inmedi Company Details
Table 84. Inmedi Business Overview
Table 85. Inmedi Molecular Diagnosis of Rectal Cancer Product
Table 86. Inmedi Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021) & (US$ Million)
Table 87. Inmedi Recent Development
Table 88. Amoydx Company Details
Table 89. Amoydx Business Overview
Table 90. Amoydx Molecular Diagnosis of Rectal Cancer Product
Table 91. Amoydx Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021) & (US$ Million)
Table 92. Amoydx Recent Development
Table 93. Genetronhealth Company Details
Table 94. Genetronhealth Business Overview
Table 95. Genetronhealth Molecular Diagnosis of Rectal Cancer Product
Table 96. Genetronhealth Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021) & (US$ Million)
Table 97. Genetronhealth Recent Development
Table 98. Berryoncology Company Details
Table 99. Berryoncology Business Overview
Table 100. Berryoncology Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021) & (US$ Million)
Table 101. Berryoncology Recent Development
Table 102. Topgen Company Details
Table 103. Topgen Business Overview
Table 104. Topgen Molecular Diagnosis of Rectal Cancer Product
Table 105. Topgen Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021) & (US$ Million)
Table 106. Topgen Recent Development
Table 107. Roche Company Details
Table 108. Roche Business Overview
Table 109. Roche Molecular Diagnosis of Rectal Cancer Product
Table 110. Roche Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021) & (US$ Million)
Table 111. Roche Recent Development
Table 112. Qiagen Company Details
Table 113. Qiagen Business Overview
Table 114. Qiagen Molecular Diagnosis of Rectal Cancer Product
Table 115. Qiagen Revenue in Molecular Diagnosis of Rectal Cancer Business (2016-2021) & (US$ Million)
Table 116. Qiagen Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnosis of Rectal Cancer Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Molecular Diagnosis of Rectal Cancer Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Molecular Diagnosis of Rectal Cancer Report Years Considered
Figure 11. Global Molecular Diagnosis of Rectal Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Molecular Diagnosis of Rectal Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Molecular Diagnosis of Rectal Cancer Market Share by Regions: 2020 VS 2027
Figure 14. Global Molecular Diagnosis of Rectal Cancer Market Share by Regions (2022-2027)
Figure 15. Global Molecular Diagnosis of Rectal Cancer Market Share by Players in 2020
Figure 16. Global Top Molecular Diagnosis of Rectal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis of Rectal Cancer as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Molecular Diagnosis of Rectal Cancer Revenue in 2020
Figure 18. Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Type (2016-2021)
Figure 19. Global Molecular Diagnosis of Rectal Cancer Revenue Market Share by Type (2022-2027)
Figure 20. North America Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Molecular Diagnosis of Rectal Cancer Market Share by Type (2016-2027)
Figure 22. North America Molecular Diagnosis of Rectal Cancer Market Share by Application (2016-2027)
Figure 23. North America Molecular Diagnosis of Rectal Cancer Market Share by Country (2016-2027)
Figure 24. United States Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Molecular Diagnosis of Rectal Cancer Market Share by Type (2016-2027)
Figure 28. Europe Molecular Diagnosis of Rectal Cancer Market Share by Application (2016-2027)
Figure 29. Europe Molecular Diagnosis of Rectal Cancer Market Share by Country (2016-2027)
Figure 30. Germany Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Molecular Diagnosis of Rectal Cancer Market Share by Region (2016-2027)
Figure 40. China Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Molecular Diagnosis of Rectal Cancer Market Share by Type (2016-2027)
Figure 48. Latin America Molecular Diagnosis of Rectal Cancer Market Share by Application (2016-2027)
Figure 49. Latin America Molecular Diagnosis of Rectal Cancer Market Share by Country (2016-2027)
Figure 50. Mexico Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Molecular Diagnosis of Rectal Cancer Market Share by Country (2016-2027)
Figure 56. Turkey Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Molecular Diagnosis of Rectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Kingmed Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
Figure 60. Geneis Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
Figure 61. Unitedgene Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
Figure 62. Yin Feng Gene Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
Figure 63. Inmedi Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
Figure 64. Amoydx Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
Figure 65. Genetronhealth Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
Figure 66. Berryoncology Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
Figure 67. Topgen Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
Figure 68. Roche Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
Figure 69. Qiagen Revenue Growth Rate in Molecular Diagnosis of Rectal Cancer Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs